.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2015 for an enormous $4...
.On the heels of a phase 3 win that neglected to blow away entrepreneurs, Ironwood Pharmaceuticals i...
.Do not quit Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball afte...
.Welcome to today's Chutes & Ladders, our summary of considerable management hirings, firings and...
.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...
.AbbVie has actually gone back to the source of its own antipsychotic powerhouse Vraylar in search o...
.GenSight Biologics is actually weeks off of lacking amount of money. Once again. The biotech merely...
.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's rare illness p...
.Along with brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ...
.After creating a gene treatment partnership with Dyno Therapeutics in 2020, Roche is actually back ...